Comparison of plasma and chemical modifications of poly-L-lactide-co-caprolactone scaffolds for heparin conjugation
Source abstract
Abstract
Abstract Biodegradable polymers have potential as a scaffold material for making small diameter artery bypass grafts. To resist thrombosis, maintain biocompatibility and enhance the remodeling of the grafts, it is crucial to modify polymer scaffolds so that the grafts have antithrombogenic capacity and allow cell infiltration. In this study, two methods of aminolysis on electrospun poly-L-lactide-co-caprolactone (PLCL) microfiber vascular grafts are compared: plasma treatment method and Fmoc-PEG-diamine insertion method. Both methods successfully inserted amino groups on the polymer graft for heparin conjugation. However, plasma treatment resulted in significantly higher initial heparin density and higher heparin stability on PLCL microfibers than Fmoc-PEG-diamine treatment. In addition, mechanical testing demonstrated that the plasma treatment method maintained PLCL microfiber tensile strength after heparin conjugation. Fmoc-PEG-diamine insertion method compromised the mechanical property due to partial fiber melting and structure disruption. Subcutaneous implantation of the grafts in a rat model showed that heparin coating with both methods promoted cell infiltration. This study provides a rationale to optimize the biomolecule conjugation on electrospun PLCL scaffolds, and will have applications in tissue engineering vascular grafts and other tissues.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Reconstructive Surgery and Microvascular Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
University of California at Berkeley, CA
Plasmatreat USA, Inc., Hayward, CA,
UC Berkeley & UCSF Joint Graduate Group in Bioengineering, CA, United States of America
University of California
Funding
National Heart, Lung, and Blood Institute
References (47)
Show source-provided references
1. Vascular tissue engineering: from in vitro to in situ10.1002/wsbm.1246 ↗
2. The effect of stromal cell-derived factor-1alpha/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration10.1016/j.biomaterials.2012.07.042 ↗
3. Long-term evaluation of a new selectively biodegradable vascular graft coated with polyethylene oxide-polylactic acid for right ventricular conduit. An experimental study10.1016/S0022-5223(19)35476-5 ↗
4. Biomaterials for vascular tissue engineering10.2217/rme.09.77 ↗
5. Characterization of electrospun poly(p-dioxanone) and poly(p-dioxanone)/clay nanocomposite fibers10.1166/jnn.2011.3323 ↗
6. Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent10.1007/s10856-011-4407-3 ↗
7. Improved hemocompatibility and endothelialization of vascular grafts by covalent immobilization of sulfated silk fibroin on poly(lactic-co-glycolic acid) scaffolds10.1021/bm200479f ↗
8. Elastomeric electrospun scaffolds of poly(L-lactide-co-trimethylene carbonate) for myocardial tissue engineering10.1007/s10856-011-4351-2 ↗
9. Seeing through the interface: poly(epsilon-caprolactone) surface modification of poly(glycerol-co-sebacic acid) membranes in adult porcine retinal explants10.1002/term.2135 ↗
10. The use of surface modified poly(glycerol-co-sebacic acid) in retinal transplantation10.1016/j.biomaterials.2009.11.074 ↗
11. Retinal transplantation using surface modified poly(glycerol-co-sebacic acid) membranes10.1016/j.biomaterials.2010.07.026 ↗
12. Fabrication of a new tubular fibrous PLCL scaffold for vascular tissue engineering10.1163/156856206778937244 ↗
13. Electrospun poly(L-lactic acid-co-varepsilon-caprolactone) fibers loaded with heparin and vascular endothelial growth factor to improve blood compatibility and endothelial progenitor cell proliferation10.1016/j.colsurfb.2015.02.023 ↗
14. The in vivo characterization of electrospun heparin-bonded polycaprolactone in small-diameter vascular reconstruction10.1177/1708538114550737 ↗
15. Electrospun fibrinogen-PLA nanofibres for vascular tissue engineering10.1002/term.2172 ↗
16. Fabrication and characterisation of biomimetic, electrospun gelatin fibre scaffolds for tunica media-equivalent, tissue engineered vascular grafts10.1016/j.msec.2015.12.081 ↗
17. Stem cell differentiation on electrospun nanofibrous substrates for vascular tissue engineering10.1016/j.msec.2013.07.021 ↗
18. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents10.1016/j.actbio.2009.07.013 ↗
19. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation10.1016/S0142-9612(00)00164-2 ↗
20. The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds10.1016/j.biomaterials.2010.01.062 ↗
21. Plasma-assisted heparin conjugation on electrospun poly(L-lactide) fibrous scaffolds10.1002/jbm.a.34802 ↗
22. Surface modification of the polymers present in a polysulfone hollow fiber hemodialyser by covalent binding of heparin or endothelial cell surface heparan sulfate: flow characteristics and platelet adhesion10.1163/156856200743689 ↗
23. Immobilization of heparin: approaches and applications10.2174/156802608783378891 ↗
24. Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures(1)10.1021/jo960057x ↗
25. New method for the methylation of amines10.1021/jo00975a049 ↗
26. Cyanohydridoborate anion as a selective reducing agent10.1021/ja00741a013 ↗
27. Lower limb revascularization for PAD using a heparin-coated PTFE conduit10.1177/1538574411401757 ↗
28. Heparin-modified small-diameter nanofibrous vascular grafts10.1109/TNB.2012.2188926 ↗
29. Surface properties and cell adhesion onto allylamine-plasma and amine-plasma coated glass coverslips10.1007/s10856-011-4245-3 ↗
30. Plasma methods for the generation of chemically reactive surfaces for biomolecule immobilization and cell colonization—a review10.1002/ppap.200600021 ↗
31. Surface modification of poly(ethylene terephthalate) by plasma polymerization of poly(ethylene glycol)10.1007/s10856-007-3033-6 ↗
32. Surface modification of nanoporous alumina membranes by plasma polymerization10.1088/0957-4484/19/24/245704 ↗
33. Surface modification by allylamine plasma polymerization promotes osteogenic differentiation of human adipose-derived stem cells10.1021/am502170s ↗
34. Chu
35. Engineering bi-layer nanofibrous conduits for peripheral nerve regeneration10.1089/ten.tec.2010.0565 ↗
36. End-point immobilization of heparin on plasma-treated surface of electrospun polycarbonate-urethane vascular graft10.1016/j.actbio.2017.01.012 ↗
37. A colorimetric method for the standardization of heparin preparations10.1042/bj0350776 ↗
38. Insight into the heparin–toluidine blue (C.I. Basic Blue 17) interaction10.1016/j.dyepig.2008.07.015 ↗
39. Toluidine blue: aggregation properties and structuralaspects10.1088/0965-0393/14/4/003 ↗
40. Colorimetric method for the assay of heparin content in immobilized heparin preparations10.1016/0003-2697(80)90679-X ↗
41. Estimation of surface-bound heparin activity: a comparison of methods10.1002/jbm.820220606 ↗
42. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice10.1038/nm.4030 ↗
43. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization10.1053/ejvs.2002.1909 ↗
44. Conditional disruption of the prolyl hydroxylase domain-containing protein 2 (Phd2) gene defines its key role in skeletal development10.1002/jbmr.2258 ↗
45. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue10.3109/10731198309118804 ↗
46. Heparin coatings for improving blood compatibility of medical devices10.1016/j.addr.2016.12.002 ↗
47. Attachment of flexible heparin chains to gelatin scaffolds improves endothelial cell infiltration10.1089/ten.tea.2011.0712 ↗